Skip to Main content Skip to Navigation
Journal articles

Relation of Body Mass Index to Outcomes in Patients With Heart Failure Implanted With Left Ventricular Assist Devices

Vincent Galand 1, 2, * Erwan Flécher 1, 2 Bernard Lelong 1 Céline Chabanne 1 Marion Charton 1 Céline Goéminne 3 André Vincentelli 3 Jean Porterie 4 Clement Delmas 4 Karine Nubret 5, 6, 7 Mathieu Pernot 5, 7, 6 Michel Kindo 8 Tam Hoang Minh 8 Philippe Gaudard 9 Philippe Rouvière 9 Thomas Sénage 10 Magali Michel 10 Aude Boignard 11 Olivier Chavanon 11 Constance Verdonk 12 Marylou Para 12 Edeline Pelcé 13 Vlad Gariboldi 13 Matteo Pozzi 14 J.-F. Obadia 15, 14 Pierre-Yves Litzler 16 Frédéric Anselme 16 Katrien Blanchart 17 Gerard Babatasi 17 Fabien Garnier 18 Marie Bielefeld 18 Costin Radu 19 David Hamon 19 Thierry Bourguignon 20 Thibaud Genet 20 Romain Eschalier 21 Nicolas D’ostrevy 21 M Bories 22 Emilie Varlet 22 Fabrice Vanhuyse 23 Nicolas Sadoul 24, 23 Christophe Leclercq 1, 2 Raphael P Martins 1, 2
Abstract : We aimed at characterizing the impact of low and high body mass index (BMI) on outcomes after left-ventricular assist device (LVAD) surgery and define the predictors of mortality in patients with abnormal BMI (low/high). This study was conducted in 19 centers from 2006 to 2016. Patients were divided based on their baseline BMI into 3 groups of BMI: low (BMI ≤18.5 kg/m²); normal (BMI = 18.5 to 24.99 kg/m²) and high (BMI ≥25 kg/m²) (including overweight (BMI = 25 to 29.99 kg/m²), and obesity (BMI ≥30 Kg/m²)). Among 652 patients, 29 (4.4%), 279 (42.8%) and 344 (52.8%) had a low-, normal-, and high BMI, respectively. Patients with high BMI were significantly more likely men, with more co-morbidities and more history of ventricular/supra-ventricular arrhythmias before LVAD implantation. Patients with abnormal BMI had significantly lower survival than those with normal BMI. Notably, those with low BMI experienced the worst survival whereas overweight or obese patients had similar survival. Four predictors of mortality for LVAD candidates with abnormal BMI were defined: total bilirubin ≥16 µmol/L before LVAD, hypertension, destination therapy, and cardiac surgery with LVAD. Depending on the number of predictor per patients, those with abnormal BMI may be divided in 3 groups of 1-year mortality risk, i.e., low (0 to 1 predictor: 29% and 31%), intermediate (2 to 3 predictors, 51% and 52%, respectively), and high (4 predictors: 83%). In conclusion, LVAD recipients with abnormal BMI experience lower survival, especially underweight patients. Four predictors of mortality have been identified for LVAD population with abnormal BMI, differentiating those a low-, intermediate-, and high risks of death.
Complete list of metadatas

Cited literature [32 references]  Display  Hide  Download
Contributor : Laurent Jonchère <>
Submitted on : Friday, November 6, 2020 - 3:08:09 PM
Last modification on : Friday, January 15, 2021 - 3:33:47 AM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2021-02-05

Please log in to resquest access to the document



Vincent Galand, Erwan Flécher, Bernard Lelong, Céline Chabanne, Marion Charton, et al.. Relation of Body Mass Index to Outcomes in Patients With Heart Failure Implanted With Left Ventricular Assist Devices. American Journal of Cardiology, Elsevier, 2020, 133, pp.81-88. ⟨10.1016/j.amjcard.2020.07.045⟩. ⟨hal-02960938⟩



Record views